{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:07:05Z","timestamp":1790554025280,"version":"4.1.0"},"reference-count":341,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.bbr.2009.06.009","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T05:03:14Z","timestamp":1244696594000},"page":"32-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders"],"prefix":"10.1016","volume":"204","author":[{"given":"Susanne","family":"Nikolaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Antke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Wilhelm","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2009.06.009_bib1","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1046\/j.1460-9568.1999.00556.x","article-title":"Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study","volume":"11","author":"Abadie","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0893-133X(98)00107-9","article-title":"No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia","volume":"20","author":"Abi-Dargham","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib4","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1523\/JNEUROSCI.22-09-03708.2002","article-title":"Prefrontal dopamine D1 receptors and working memory in schizophrenia","volume":"22","author":"Abi-Dargham","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib5","first-page":"166","article-title":"Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us?","volume":"2","author":"Abi-Dargham","year":"2003","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2004.01.018","article-title":"Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide","volume":"55","author":"Abi-Dargham","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02439541","article-title":"Multivariate cluster analysis of dynamic iodine-123 iodobenzamide SPET dopamine D2 receptor images in schizophrenia","volume":"24","author":"Acton","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S1461145705005055","article-title":"Patients with obsessive\u2013compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei","volume":"8","author":"Adams","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2009.06.009_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00002826-199201001-00123","article-title":"PET studies with l-[11C]5-HTP and l-[11C]dopa in brains of healthy volunteers and patients with major depression","volume":"15","author":"Agren","year":"1992","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1055\/s-2007-1014265","article-title":"PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers","volume":"27","author":"Agren","year":"1994","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.WNL.0000076181.39162.FC","article-title":"Increased ventral striatal monoaminergic innervation in Tourette syndrome","volume":"61","author":"Albin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.06.009_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2009.06.009_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000106476","article-title":"A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls","volume":"55","author":"Amsterdam","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbr.2009.06.009_bib14","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1176\/appi.ajp.157.7.1108","article-title":"Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients","volume":"157","author":"Anand","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2005.08.016","article-title":"Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study","volume":"89","author":"Argyelan","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0006-3223(98)00007-9","article-title":"The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine","volume":"45","author":"Attar-L\u00e9vy","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002590000392","article-title":"Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients","volume":"28","author":"Audenaert","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pscychresns.2007.07.004","article-title":"Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters","volume":"162","author":"Bah","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-3223(97)00300-4","article-title":"Cognitive functioning and GABAA\/benzodiazepine receptor binding in schizophrenia: a 123I-iomazenil SPET study","volume":"43","author":"Ball","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"9 Suppl 14","key":"10.1016\/j.bbr.2009.06.009_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S1092852900026924","article-title":"The medical treatment of obsessive\u2013compulsive disorder and anxiety","volume":"13","author":"Bandelow","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1016\/j.bbr.2009.06.009_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/026988110401800304","article-title":"A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment","volume":"18","author":"Bantick","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.31887\/DCNS.2006.8.2\/fbenazzi","article-title":"Various forms of depression","volume":"8","author":"Benazzi","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib23","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(07)60453-X","article-title":"Bipolar disorder\u2014focus on bipolar II disorder and mixed depression","volume":"369","author":"Benazzi","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2009.06.009_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.mp.4001401","article-title":"Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635","volume":"9","author":"Bhagwagar","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib25","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1176\/ajp.2006.163.9.1580","article-title":"Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907","volume":"163","author":"Bhagwagar","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib26","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1176\/appi.ajp.2007.06111933","article-title":"5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB","volume":"164","author":"Bhagwagar","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2009.06.009_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-5122(02)00009-9","article-title":"Depression, menopause and estrogens: is there a correlation?","volume":"41","author":"Birkh\u00e4user","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.bbr.2009.06.009_bib28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1192\/bjp.171.5.444","article-title":"Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex","volume":"171","author":"Biver","year":"1997","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib29","series-title":"Dementia praecox or the group of schizophrenias","author":"Bleuler","year":"1911"},{"key":"10.1016\/j.bbr.2009.06.009_bib30","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/ajmg.b.30699","article-title":"Association of the serotonin transporter polymorphism and obsessive\u2013compulsive disorder: systematic review","volume":"147B","author":"Bloch","year":"2008","journal-title":"Am J Med Genet B: Neuropsychiatr Genet"},{"key":"10.1016\/j.bbr.2009.06.009_bib31","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","article-title":"Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB","volume":"23","author":"Boileau","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.schres.2008.09.011","article-title":"Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging","volume":"106","author":"Bose","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.neubiorev.2007.03.001","article-title":"The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders","volume":"31","author":"Bourin","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2009.06.009_bib34","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s007020050134","article-title":"Increased benzodiazepine receptor density in the prefrontal cortex in patients with panic disorder","volume":"105","author":"Brandt","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2009.06.009_bib35","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2009.06.009_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(99)00188-2","article-title":"SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder","volume":"47","author":"Bremner","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib37","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/appi.ajp.157.7.1120","article-title":"Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder","volume":"157","author":"Bremner","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biopsych.2005.03.016","article-title":"Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-d-aspartate receptors in vivo","volume":"58","author":"Bressan","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib39","article-title":"Studies on hysteria","volume":"vol. 1","author":"Breuer","year":"1895"},{"key":"10.1016\/j.bbr.2009.06.009_bib40","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1469-7610.2007.01799.x","article-title":"Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit\/hyperactivity disorder","volume":"48","author":"Brieber","year":"2007","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib41","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1176\/appi.ajp.160.10.1836","article-title":"Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging","volume":"160","author":"Brunswick","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.schres.2006.03.042","article-title":"D2\/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia","volume":"85","author":"Buchsbaum","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib43","first-page":"56","article-title":"Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia","volume":"154","author":"Busatto","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biopsych.2006.05.005","article-title":"Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography","volume":"60","author":"Cannon","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.biopsych.2007.03.016","article-title":"Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder","volume":"62","author":"Cannon","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1399-5618.2007.00558.x","article-title":"Pure and mixed manic subtypes: a review of diagnostic classification and validation","volume":"10","author":"Cassidy","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/000992289703600702","article-title":"Toward a pathophysiology of attention-deficit\/hyperactivity disorder","volume":"36","author":"Castellanos","year":"1997","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.bbr.2009.06.009_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-006-0540-y","article-title":"Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study","volume":"189","author":"Catafau","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00259-002-1047-3","article-title":"Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder","volume":"30","author":"Cheon","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bbr.2009.06.009_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pscychresns.2003.06.001","article-title":"Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder","volume":"130","author":"Cheon","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/schbul\/14.2.169","article-title":"From syndrome to illness: delineating the pathophysiology of schizophrenia with PET","volume":"14","author":"Cohen","year":"1988","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbr.2009.06.009_bib52","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000104704","article-title":"Sudden glory revisited: cognitive contents of hypomania","volume":"76","author":"Colom","year":"2007","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.bbr.2009.06.009_bib53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/oxfordjournals.schbul.a007038","article-title":"The stress cascade and schizophrenia: etiology and onset","volume":"29","author":"Corcoran","year":"2003","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbr.2009.06.009_bib54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.neuroimage.2005.07.038","article-title":"Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis","volume":"29","author":"Corripio","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbr.2009.06.009_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00006231-198608000-00006","article-title":"Uptake of 77Br-spiperone in the striata of schizophrenic patients and controls","volume":"7","author":"Crawley","year":"1986","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.bbr.2009.06.009_bib56","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(86)92525-0","article-title":"Dopamine D2 receptors in schizophrenia studied in vivo","volume":"2","author":"Crawley","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2009.06.009_bib57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.mp.4000766","article-title":"Elevated hypothalamic\/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents","volume":"5","author":"Dahlstrom","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0920-9964(96)00102-8","article-title":"Presynaptic dopaminergic function in the striatum of schizophrenic patients","volume":"23","author":"Dao-Castellana","year":"1997","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib59","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.2174\/156802608785161439","article-title":"5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders","volume":"8","author":"Dawson","year":"2008","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bbr.2009.06.009_bib60","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2165\/00003495-200868080-00008","article-title":"Olanzapine\/fluoxetine: a review of its use in the treatment of acute bipolar depression","volume":"68","author":"Deeks","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.bbr.2009.06.009_bib61","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.biopsych.2004.01.023","article-title":"Low level of dopaminergic D2 receptor binding in obsessive\u2013compulsive disorder","volume":"55","author":"Denys","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0925-4927(92)90018-Y","article-title":"SPECT imaging of serotonin2 receptors in depression","volume":"45","author":"D\u2019haenen","year":"1992","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0006-3223(94)91202-5","article-title":"Dopamine D2 receptors in depression measured with single photon emission computed tomography","volume":"35","author":"D\u2019haenen","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib64","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2174\/156802606778522113","article-title":"Central serotonin2C receptor: from physiology to pathology","volume":"6","author":"Di Giovanni","year":"2006","journal-title":"Curr Top Med Chem"},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2009.06.009_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-992133","article-title":"Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action","volume":"40","author":"Di Pietro","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib66","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0140-6736(99)04030-1","article-title":"Dopamine transporter density in patients with attention deficit hyperactivity disorder","volume":"354","author":"Dougherty","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2009.06.009_bib67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/da.20168","article-title":"Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks","volume":"23","author":"Dougherty","year":"2006","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.bbr.2009.06.009_bib68","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s002590000330","article-title":"Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment","volume":"27","author":"Dresel","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib69","first-page":"261","article-title":"Neuroanatomical circuits in depression: implications for treatment mechanisms","volume":"28","author":"Drevets","year":"1992","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.bbr.2009.06.009_bib70","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","article-title":"PET imaging of serotonin 1A receptor binding in depression","volume":"46","author":"Drevets","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib71","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0969-8051(00)00119-0","article-title":"Serotonin type-1A receptor imaging in depression","volume":"27","author":"Drevets","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bbr.2009.06.009_bib72","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.nucmedbio.2007.06.008","article-title":"Serotonin-1A receptor imaging in recurrent depression: replication and literature review","volume":"34","author":"Drevets","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bbr.2009.06.009_bib73","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-3223(94)90024-8","article-title":"Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation\u2014preliminary results","volume":"35","author":"Ebert","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02246416","article-title":"Dopamine and depression\u2014striatal dopamine D2 receptor SPECT before and after antidepressant therapy","volume":"126","author":"Ebert","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4927(00)00064-0","article-title":"6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography","volume":"100","author":"Elkashef","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib76","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1523\/JNEUROSCI.18-15-05901.1998","article-title":"DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study","volume":"18","author":"Ernst","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib77","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/ajp.156.8.1209","article-title":"High midbrain DOPA accumulation in children with attention deficit hyperactivity disorder","volume":"156","author":"Ernst","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib78","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.npp.1301656","article-title":"Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients","volume":"33","author":"Erritzoe","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archpsyc.1987.01800190091013","article-title":"No D2 receptor increase in PET study of schizophrenia","volume":"44","author":"Farde","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archpsyc.1990.01810150013003","article-title":"D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride","volume":"47","author":"Farde","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib81","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3810\/pgm.2008.09.1903","article-title":"Commentary: why diagnose and treat ADHD in adults?","volume":"120","author":"Feifel","year":"2008","journal-title":"Postgrad Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1744-9081-2-40","article-title":"Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder","volume":"2","author":"Forssberg","year":"2006","journal-title":"Behav Brain Funct"},{"key":"10.1016\/j.bbr.2009.06.009_bib83","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.biopsych.2005.02.028","article-title":"Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB","volume":"57","author":"Frankle","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-006-0543-8","article-title":"Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [(11)C]WAY 100635","volume":"189","author":"Frankle","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib85","article-title":"Neuropsychoses of defense. An attempt at a psychological theory of acquired hysteria, of many phobias and obsessions and of certain hallucinatory psychoses","volume":"vol. 1","author":"Freud","year":"1896"},{"key":"10.1016\/j.bbr.2009.06.009_bib86","article-title":"Analysis of a phobia of a five-year-old boy","volume":"vol. 1","author":"Freud","year":"1905"},{"key":"10.1016\/j.bbr.2009.06.009_bib87","article-title":"Fragment of a case of hysteria","volume":"vol. 5","author":"Freud","year":"1905"},{"key":"10.1016\/j.bbr.2009.06.009_bib88","article-title":"Note on a case of obsessional neurosis","volume":"vol. 7","author":"Freud","year":"1905"},{"key":"10.1016\/j.bbr.2009.06.009_bib89","article-title":"Mourning and melancholy","volume":"vol. 10","author":"Freud","year":"1916"},{"key":"10.1016\/j.bbr.2009.06.009_bib90","article-title":"Beyond the pleasure principle","volume":"vol. 13","author":"Freud","year":"1920"},{"key":"10.1016\/j.bbr.2009.06.009_bib91","article-title":"Group psychology and the analysis of the Ego","volume":"vol. 13","author":"Freud","year":"1921"},{"key":"10.1016\/j.bbr.2009.06.009_bib92","article-title":"The Id and the Ego","volume":"vol. 13","author":"Freud","year":"1923"},{"key":"10.1016\/j.bbr.2009.06.009_bib93","article-title":"The loss of reality in neurosis and psychosis","volume":"vol. 13","author":"Freud","year":"1924"},{"key":"10.1016\/j.bbr.2009.06.009_bib94","article-title":"Inhibition, symptom and anxiety","volume":"vol. 14","author":"Freud","year":"1926"},{"key":"10.1016\/j.bbr.2009.06.009_bib95","article-title":"The future of an illusion","volume":"vol. 14","author":"Freud","year":"1927"},{"key":"10.1016\/j.bbr.2009.06.009_bib96","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0006-3223(92)90111-C","article-title":"Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia","volume":"32","author":"Geaney","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib97","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/1467-9450.00347","article-title":"Different corticostriatal patterns of l-DOPA decarboxylase activity in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine","volume":"44","author":"Gefvert","year":"2003","journal-title":"Scand J Psychol"},{"key":"10.1016\/j.bbr.2009.06.009_bib98","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0925-4927(94)90014-0","article-title":"Dopamine receptor availability in Tourette's syndrome","volume":"55","author":"George","year":"1994","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib99","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.mp.4002054","article-title":"Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder","volume":"13","author":"Geuze","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib100","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1212\/01.wnl.0000242733.18534.2c","article-title":"Altered mesolimbocortical and thalamic dopamine in Tourette syndrome","volume":"67","author":"Gilbert","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.06.009_bib101","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib102","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1314.008","article-title":"Trauma, genes, and the neurobiology of personality disorders","volume":"1032","author":"Goodman","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbr.2009.06.009_bib103","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/oxfordjournals.bmb.a011563","article-title":"Functional imaging, affective disorder and dementia","volume":"52","author":"Goodwin","year":"1996","journal-title":"Br Med Bull"},{"key":"10.1016\/j.bbr.2009.06.009_bib104","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0920-9964(95)00034-J","article-title":"Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET","volume":"17","author":"Gray","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib105","first-page":"21","article-title":"Classification of mood disorders in adults","volume":"5","author":"Guelfi","year":"1995","journal-title":"Encephale"},{"key":"10.1016\/j.bbr.2009.06.009_bib106","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0193-953X(05)70141-6","article-title":"Neurotransmitter dysfunction in patients with borderline personality disorder","volume":"23","author":"Gurvits","year":"2000","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.bbr.2009.06.009_bib107","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(03)12379-3","article-title":"Genes for schizophrenia? Recent findings and their pathophysiological implications","volume":"361","author":"Harrison","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2009.06.009_bib108","first-page":"159","article-title":"Positron emission tomography of [11C]5-hydroxytryptophan utilization in the brains of healthy volunteers and a patient with major depression","volume":"376","author":"Hartvig","year":"1991","journal-title":"Acta Radiol Suppl"},{"key":"10.1016\/j.bbr.2009.06.009_bib109","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.biopsych.2007.02.015","article-title":"5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression","volume":"62","author":"Hasler","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib110","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archpsyc.65.10.1166","article-title":"Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography","volume":"65","author":"Hasler","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib111","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-0447.2006.00940.x","article-title":"Reduced midbrain-pons serotonin transporter binding in patients with obsessive\u2013compulsive disorder","volume":"115","author":"Hasselbalch","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.bbr.2009.06.009_bib112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S1461145706006559","article-title":"Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome","volume":"10","author":"Haugbol","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib113","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00406-002-0389-y","article-title":"Cognitive-behavioural theories of helplessness\/hopelessness: valid models of depression?","volume":"252","author":"Henkel","year":"2002","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib114","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ncl.2006.03.006","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis, glucocorticoids, and neurologic disease","volume":"24","author":"Herman","year":"2006","journal-title":"Neurol Clin"},{"key":"10.1016\/j.bbr.2009.06.009_bib115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00702-005-0429-7","article-title":"Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM","volume":"113","author":"Herold","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2009.06.009_bib116","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pscychresns.2005.07.002","article-title":"Serotonin and dopamine transporter imaging in patients with obsessive\u2013compulsive disorder","volume":"140","author":"Hesse","year":"2005","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib117","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archpsyc.1994.03950020040004","article-title":"Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography","volume":"51","author":"Hietala","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib118","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(95)91801-9","article-title":"Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients","volume":"346","author":"Hietala","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2009.06.009_bib119","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(98)00113-3","article-title":"Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia","volume":"35","author":"Hietala","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archpsyc.62.4.371","article-title":"Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia","volume":"62","author":"Hirvonen","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib121","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1176\/ajp.2006.163.10.1747","article-title":"Brain dopamine d1 receptors in twins discordant for schizophrenia","volume":"163","author":"Hirvonen","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib122","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S1461145707008140","article-title":"Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635","volume":"11","author":"Hirvonen","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib123","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00213-008-1088-9","article-title":"Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET","volume":"197","author":"Hirvonen","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib124","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/msj.20041","article-title":"Anxiety disorders: a comprehensive review of pharmacotherapies","volume":"75","author":"Hoffman","year":"2008","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00702-007-0014-3","article-title":"Is onset of Tourette syndrome influenced by life events?","volume":"115","author":"Horesh","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2009.06.009_bib126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0920-9964(03)00006-9","article-title":"Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1","volume":"65","author":"Hsiao","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib127","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00429-005-0036-2","article-title":"Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia","volume":"210","author":"Hurlemann","year":"2005","journal-title":"Anat Embryol (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00213-007-0921-x","article-title":"5-HT2A receptor density is decreased in the at-risk mental state","volume":"195","author":"Hurlemann","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pscychresns.2007.04.006","article-title":"[99mTc]TRODAT-1\/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome","volume":"162","author":"Hwang","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib130","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0006-3223(01)01351-8","article-title":"Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652","volume":"51","author":"Ichimiya","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib131","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.euroneuro.2004.10.001","article-title":"Histamine H1 receptors in schizophrenic patients measured by positron emission tomography","volume":"15","author":"Iwabuchi","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib132","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/mds.870110621","article-title":"Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome","volume":"11","author":"Jauss","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib133","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pscychresns.2006.08.001","article-title":"Reduced midbrain serotonin transporter availability in drug-na\u00efve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging","volume":"154","author":"Joensuu","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib134","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biopsych.2004.11.009","article-title":"Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit\/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity","volume":"57","author":"Jucaite","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3928\/0090-4481-20050201-09","article-title":"Separation anxiety disorder","volume":"34","author":"Jurbergs","year":"2005","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.bbr.2009.06.009_bib136","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1460-9568.2004.03540.x","article-title":"Decreased histamine H1 receptor binding in the brain of depressed patients","volume":"20","author":"Kano","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib137","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/appi.ajp.159.5.761","article-title":"PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia","volume":"159","author":"Karlsson","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib138","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-3956(95)00019-2","article-title":"Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT","volume":"29","author":"Kaschka","year":"1995","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-1819.2007.01604.x","article-title":"Molecular genetics of bipolar disorder and depression","volume":"61","author":"Kato","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.31887\/DCNS.2008.10.3\/shkennedy","article-title":"Core symptoms of major depressive disorder: relevance to diagnosis and treatment","volume":"10","author":"Kennedy","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib141","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00259-003-1245-7","article-title":"Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive\u2013compulsive disorder","volume":"30","author":"Kim","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bbr.2009.06.009_bib142","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0925-4927(99)00009-8","article-title":"Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT","volume":"90","author":"Klimke","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib143","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1192\/bjp.171.6.574","article-title":"Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT study","volume":"171","author":"Knable","year":"1997","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib144","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/026988119701100205","article-title":"Dopamine, the prefrontal cortex and schizophrenia","volume":"11","author":"Knable","year":"1997","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1139\/jpn.0723","article-title":"[I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects","volume":"32","author":"Koch","year":"2007","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib146","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(02)00328-5","article-title":"Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment","volume":"97","author":"Konradi","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2009.06.009_bib147","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.npp.1300353","article-title":"Diminished GABA(A) receptor-binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety","volume":"29","author":"Kosel","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib148","unstructured":"Kraepelin E. Manic-depressive insanity. In: Kraepelin E, editor. Psychiatrie. Ein Lehrbuch. II. Teil. Leipzig: Barth; 1913, p. 1183\u2013395."},{"key":"10.1016\/j.bbr.2009.06.009_bib149","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3940(00)01040-5","article-title":"Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography","volume":"285","author":"Krause","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2009.06.009_bib150","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s00415-002-0746-9","article-title":"Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit\/hyperactivity disorder: positive effect of methylphenidate","volume":"249","author":"Krause","year":"2002","journal-title":"J Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.bbr.2009.06.009_bib151","first-page":"56","article-title":"Bipolar disorders: the disease of extreme emotions","volume":"149","author":"Kr\u00fcger","year":"2007","journal-title":"MMW Fortschr Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib152","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0006-3223(02)01788-2","article-title":"Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT","volume":"54","author":"Kugaya","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib153","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00006231-199504000-00159","article-title":"Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder","volume":"16","author":"Kuikka","year":"1995","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.bbr.2009.06.009_bib154","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1523\/JNEUROSCI.0805-07.2007","article-title":"Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa\/positron emission tomography study","volume":"27","author":"Kumakura","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/appi.ajp.157.2.269","article-title":"Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography","volume":"157","author":"Laakso","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib156","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-9964(00)00095-5","article-title":"Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia","volume":"52","author":"Laakso","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib157","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s002130051005","article-title":"Striatal dopamine transporter density in major depression","volume":"144","author":"Laasonen-Balk","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib158","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.mnm.0000230077.48480.68","article-title":"Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder","volume":"27","author":"La Fougere","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.bbr.2009.06.009_bib159","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.encep.2007.07.007","article-title":"The schizotypal personality disorder: historical origins and current status","volume":"34","author":"Laguerre","year":"2008","journal-title":"Encephale"},{"key":"10.1016\/j.bbr.2009.06.009_bib160","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib161","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biopsych.2006.05.022","article-title":"Reduced serotonin-1A receptor binding in social anxiety disorder","volume":"61","author":"Lanzenberger","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib162","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/nimg.1997.0267","article-title":"In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression","volume":"5","author":"Larisch","year":"1997","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbr.2009.06.009_bib163","first-page":"245","article-title":"Clinical impact of cerebral dopamine-D2 receptor scintigraphy","volume":"37","author":"Larisch","year":"1998","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.bbr.2009.06.009_bib164","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0038-1625925","article-title":"Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder","volume":"40","author":"Larisch","year":"2001","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.bbr.2009.06.009_bib165","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1055\/s-2004-825925","article-title":"Depression and anxiety in different thyroid function states","volume":"36","author":"Larisch","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib166","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00006231-200603000-00010","article-title":"Striatal dopamine transporter density in drug naive patients with attention-deficit\/hyperactivity disorder","volume":"27","author":"Larisch","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.bbr.2009.06.009_bib167","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2009.06.009_bib168","first-page":"211","article-title":"Imaging dopamine transmission in schizophrenia. A review and meta-analysis","volume":"42","author":"Laruelle","year":"1998","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib169","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(99)00067-0","article-title":"Increased dopamine transmission in schizophrenia: relationship to illness phases","volume":"46","author":"Laruelle","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0006-3223(99)00257-7","article-title":"Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT","volume":"47","author":"Laruelle","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib171","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s007020170043","article-title":"Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET","volume":"108","author":"Lauer","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2009.06.009_bib172","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-9964(00)00023-2","article-title":"Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT","volume":"47","author":"Lavalaye","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib173","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.pnpbp.2006.03.019","article-title":"Midbrain binding of [123I]nor-beta-CIT in atypical depression","volume":"30","author":"Lehto","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib174","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neulet.2008.06.042","article-title":"Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study","volume":"441","author":"Lehto","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2009.06.009_bib175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1440-1819.2008.01814.x","article-title":"Temporal cortex dopamine D2\/3 receptor binding in major depression","volume":"62","author":"Lehto","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib176","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.mp.4001306","article-title":"Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks","volume":"8","author":"Lenox","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib177","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1176\/ajp.156.1.72","article-title":"Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects","volume":"156","author":"Lewis","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib178","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.euroneuro.2005.09.006","article-title":"alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters","volume":"16","author":"Leyton","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib179","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.psc.2007.04.005","article-title":"Schizophrenia: measurements of psychopathology","volume":"30","author":"Lindenmayer","year":"2007","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.bbr.2009.06.009_bib180","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0006-3223(99)00109-2","article-title":"Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by l-(beta-11C) DOPA and PET","volume":"46","author":"Lindstrom","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib181","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.euroneuro.2003.11.001","article-title":"Impulsivity related to brain serotonin transporter binding capacity in suicide attempters","volume":"14","author":"Lindstr\u00f6m","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib182","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neuroimage.2008.02.025","article-title":"Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study","volume":"41","author":"Ludolph","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbr.2009.06.009_bib183","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1399-5618.2007.00564.x","article-title":"Schizoaffective disorder: diagnostic issues and future recommendations","volume":"10","author":"Malhi","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib184","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1176\/ajp.152.9.1359","article-title":"[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder","volume":"152","author":"Malison","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib185","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0006-3223(98)00272-8","article-title":"Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography","volume":"44","author":"Malison","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib186","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archpsyc.55.8.715","article-title":"Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study","volume":"55","author":"Malizia","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib187","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2003-43051","article-title":"Fluoxetine in Alzheimer's disease with severe obsessive compulsive symptoms and a low density of serotonin transporter sites","volume":"36","author":"Marksteiner","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib188","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00406-004-0520-3","article-title":"SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder","volume":"254","author":"Maron","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib189","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pscychresns.2003.10.004","article-title":"Reduced brain serotonin transporter binding in patients with panic disorder","volume":"132","author":"Maron","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib190","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0165-1781(89)90088-7","article-title":"Striatal D2 dopaminergic receptor status ascertained in vivo by positron emission tomography and 76Br-bromospiperone in untreated schizophrenics","volume":"29","author":"Martinot","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib191","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/ajp.147.1.44","article-title":"Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients","volume":"147","author":"Martinot","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib192","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1192\/bjp.158.3.346","article-title":"The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride","volume":"158","author":"Martinot","year":"1991","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib193","first-page":"127","article-title":"Central dopaminergic receptors and negative symptoms in schizophreni","volume":"150","author":"Martinot","year":"1992","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.bbr.2009.06.009_bib194","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1192\/bjp.164.1.27","article-title":"Central D2 receptors and negative symptoms of schizophrenia","volume":"164","author":"Martinot","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-005-2250-2","article-title":"Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism","volume":"181","author":"Mateos","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib196","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1157\/13088411","article-title":"Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone","volume":"25","author":"Mateos","year":"2006","journal-title":"Rev Esp Med Nucl"},{"key":"10.1016\/j.bbr.2009.06.009_bib197","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00213-006-0570-5","article-title":"Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait","volume":"191","author":"Mateos","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib198","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/17.4.609","article-title":"Classical subtypes for schizophrenia: literature review for DSM-IV","volume":"17","author":"McGlashan","year":"1991","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbr.2009.06.009_bib199","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-2008-1076727","article-title":"Striatal D2\/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study","volume":"41","author":"Meisenzahl","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib200","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1176\/ajp.156.12.1871","article-title":"PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders","volume":"156","author":"Meltzer","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib201","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-002-1379-5","article-title":"5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study","volume":"167","author":"Messa","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib202","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/ajp.156.7.1029","article-title":"Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study","volume":"156","author":"Meyer","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib203","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/appi.ajp.158.1.78","article-title":"The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study","volume":"158","author":"Meyer","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib204","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1097\/00001756-200112210-00052","article-title":"Lower dopamine transporter binding potential in striatum during depression","volume":"12","author":"Meyer","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2009.06.009_bib205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/appi.ajp.160.1.90","article-title":"Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm","volume":"160","author":"Meyer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib206","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archpsyc.61.12.1271","article-title":"Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes","volume":"61","author":"Meyer","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib207","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1176\/ajp.2006.163.9.1594","article-title":"Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study","volume":"163","author":"Meyer","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib208","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.53.2.371","article-title":"Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome","volume":"53","author":"Meyer","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.06.009_bib209","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biopsych.2003.08.015","article-title":"Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography","volume":"55","author":"Mintun","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib211","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jad.2006.11.010","article-title":"Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride","volume":"101","author":"Montgomery","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.npp.1301199","article-title":"Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-na\u00efve patients","volume":"32","author":"Moresco","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib213","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/PL00007806","article-title":"Dopamine transporter binding in Gilles de la Tourette syndrome","volume":"247","author":"M\u00fcller-Vahl","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.bbr.2009.06.009_bib214","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2000.101003165.x","article-title":"Dopamine D2 receptor imaging in Gilles de la Tourette syndrome","volume":"101","author":"M\u00fcller-Vahl","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.bbr.2009.06.009_bib215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2005.05.031","article-title":"Serotonin transporter binding in Tourette syndrome","volume":"385","author":"M\u00fcller-Vahl","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2009.06.009_bib216","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.bp.107.041186","article-title":"Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study","volume":"193","author":"Nash","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib217","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1017\/S003329170105434z","article-title":"Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls","volume":"31","author":"Neumeister","year":"2001","journal-title":"Psychol Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib218","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1523\/JNEUROSCI.4921-03.2004","article-title":"Reduced serotonin type 1A receptor binding in panic disorder","volume":"24","author":"Neumeister","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib219","first-page":"973","article-title":"123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study","volume":"46","author":"Newberg","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib220","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1176\/appi.ajp.157.6.1016","article-title":"Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone","volume":"157","author":"Ngan","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib221","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/00001756-199908020-00013","article-title":"The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection","volume":"10","author":"Nikolaus","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2009.06.009_bib222","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(00)00902-2","article-title":"Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P","volume":"283","author":"Nikolaus","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2009.06.009_bib223","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/REVNEURO.2004.15.2.131","article-title":"The contribution of small animal positron emission tomography to the neurosciences\u2014a critical evaluation","volume":"15","author":"Nikolaus","year":"2004","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib224","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.mp.4001693","article-title":"In vivo snapshots of the dopaminergic synapse in small animals","volume":"10","author":"Nikolaus","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib225","first-page":"473","article-title":"Investigating the dopaminergic synapse in vivo. II. Molecular imaging studies in small laboratory animals","volume":"18","author":"Nikolaus","year":"2007","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0925-4927(95)02732-D","article-title":"No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone","volume":"61","author":"Nordstrom","year":"1995","journal-title":"Psychiatry Res"},{"issue":"Suppl 6","key":"10.1016\/j.bbr.2009.06.009_bib227","first-page":"3","article-title":"The role of dopamine and norepinephrine in depression and antidepressant treatment","volume":"67","author":"Nutt","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib228","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/385634a0","article-title":"Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET","volume":"385","author":"Okubo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2009.06.009_bib229","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/S0024-3205(00)80005-3","article-title":"Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography","volume":"66","author":"Okubo","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2009.06.009_bib230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2008.06.020","article-title":"Dopamine D1 receptor binding in the striatum of patients with obsessive\u2013compulsive disorder","volume":"114","author":"Olver","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib231","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(01)01089-7","article-title":"Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression","volume":"50","author":"Parsey","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib232","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/appi.ajp.163.1.52","article-title":"Lower serotonin transporter binding potential in the human brain during major depressive episodes","volume":"163","author":"Parsey","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib233","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2005.06.016","article-title":"Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study","volume":"59","author":"Parsey","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib234","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.npp.1300992","article-title":"Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study","volume":"31","author":"Parsey","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib235","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/schbul\/19.4.783","article-title":"Quantitative D2 dopamine receptor PET and structural MRI changes in late-onset schizophrenia","volume":"19","author":"Pearlson","year":"1993","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbr.2009.06.009_bib236","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1995.03950180057008","article-title":"In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder","volume":"52","author":"Pearlson","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib237","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1017\/S0033291700027392","article-title":"Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia","volume":"24","author":"Pedro","year":"1994","journal-title":"Psychol Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib238","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive\u2013compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbr.2009.06.009_bib239","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0278-5846(03)00106-4","article-title":"Preliminary evidence of striatal D2 receptor density as a possible biological marker of prognosis in naive schizophrenic patients","volume":"27","author":"P\u00e9rez","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib240","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1176\/ajp.155.11.1592","article-title":"A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"155","author":"Perlmutter","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib241","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1017\/S0033291700025575","article-title":"Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study","volume":"23","author":"Pilowsky","year":"1993","journal-title":"Psychol Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib242","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1192\/bjp.164.1.16","article-title":"D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study","volume":"164","author":"Pilowsky","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib243","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.mp.4001751","article-title":"First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients","volume":"11","author":"Pilowsky","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib244","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0006-3223(03)00183-5","article-title":"Elevated brain serotonin transporter availability in patients with obsessive\u2013compulsive disorder","volume":"54","author":"Pogarell","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib245","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2710.2000.00281.x","article-title":"Pharmacogenetics and psychopharmacotherapy","volume":"25","author":"Poolsup","year":"2000","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.bbr.2009.06.009_bib246","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.ajp.160.1.118","article-title":"In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia","volume":"160","author":"Raedler","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib247","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0278-5846(03)00085-X","article-title":"Depression in premenopausal women: gonadal hormones and serotonergic system assessed by d-fenfluramine challenge test","volume":"27","author":"Rajewska","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib248","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.apnu.2007.08.005","article-title":"Evolution of posttraumatic stress disorder and future directions","volume":"22","author":"Ray","year":"2008","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1016\/j.bbr.2009.06.009_bib249","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00702-007-0785-6","article-title":"Reduced availability of serotonin transporters in obsessive\u2013compulsive disorder correlates with symptom severity\u2014a [11C]DASB PET study","volume":"114","author":"Reimold","year":"2007","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2009.06.009_bib250","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/sj.mp.4002149","article-title":"Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study","volume":"13","author":"Reimold","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib251","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1073\/pnas.91.24.11651","article-title":"Elevated dopa decarboxylase activity in living brain of patients with psychosis","volume":"91","author":"Reith","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2009.06.009_bib252","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2003.12.014","article-title":"PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression","volume":"82","author":"Reivich","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib253","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2009.06.009_bib254","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/YPG.0b013e328015b937","article-title":"The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree","volume":"17","author":"Robertson","year":"2007","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.bbr.2009.06.009_bib255","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.neuroimage.2004.11.031","article-title":"Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder","volume":"25","author":"Rosa-Neto","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbr.2009.06.009_bib256","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bbr.2009.06.009_bib257","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pscychresns.2006.06.001","article-title":"Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy","volume":"148","author":"Ryding","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib258","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/milmed\/165.6.473","article-title":"Increased regional cerebral perfusion by 99mTc hexamethyl propylene amine oxime single photon emission computed tomography in post-traumatic stress disorder","volume":"165","author":"Sachinvala","year":"2000","journal-title":"Mil Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib259","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pscychresns.2006.03.001","article-title":"Dopamine transporter binding in depressed patients with anhedonia","volume":"147","author":"Sarchiapone","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib260","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1054\/mehy.2001.1391","article-title":"Manic depressive psychosis and schizophrenia are neurological disorders at the extremes of CNS maturation and nutritional disorders associated with a deficit in marine fat","volume":"57","author":"Saugstad","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.bbr.2009.06.009_bib261","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","article-title":"Contemporary assessment and pharmacotherapy of Tourette syndrome","volume":"3","author":"Scahill","year":"2006","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbr.2009.06.009_bib262","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cpr.2005.01.005","article-title":"Cognitive reactivity and vulnerability: empirical evaluation of construct activation and cognitive diatheses in unipolar depression","volume":"25","author":"Scher","year":"2005","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.bbr.2009.06.009_bib263","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pscychresns.2005.05.002","article-title":"Increased cerebral serotonin-2A receptor binding in depressed patients with myocardial infarction","volume":"139","author":"Schins","year":"2005","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib264","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02279812","article-title":"Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report","volume":"244","author":"Schlegel","year":"1994","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib265","doi-asserted-by":"crossref","first-page":"488493","DOI":"10.1177\/0269881105056530","article-title":"The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1","volume":"19","author":"Schmitt","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib266","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00406-005-0618-2","article-title":"Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients","volume":"256","author":"Schmitt","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib267","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2007.11.010","article-title":"Dual-isotope SPECT imaging of striatal dopamine: first episode, drug na\u00efve schizophrenic patients","volume":"101","author":"Schmitt","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib268","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/appi.ajp.157.3.457","article-title":"Low dopamine D(2) receptor binding potential in social phobia","volume":"157","author":"Schneier","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib269","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.20268","article-title":"Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings","volume":"25","author":"Schneier","year":"2008","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.bbr.2009.06.009_bib270","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/da.20177","article-title":"A biopsychosocial model as a guide for psychoeducation and treatment of depression","volume":"23","author":"Schotte","year":"2006","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.bbr.2009.06.009_bib271","first-page":"209","article-title":"Overview of epidemiology, clinical features, genetics, neurobiology, and prognosis of adolescent attention-deficit\/hyperactivity disorder","volume":"19","author":"Schubiner","year":"2008","journal-title":"Adolesc Med State Art Rev"},{"key":"10.1016\/j.bbr.2009.06.009_bib272","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0925-4927(98)00026-2","article-title":"Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy?","volume":"83","author":"Schwarz","year":"1998","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib273","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.bbr.2009.06.009_bib274","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0024-3205(87)90169-X","article-title":"Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients","volume":"41","author":"Sedvall","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2009.06.009_bib275","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.0001-690X.2004.00214.x","article-title":"Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT\/SPECT study","volume":"109","author":"Serra-Mestres","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.bbr.2009.06.009_bib276","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/mp.2008.29","article-title":"The genetics of bipolar disorder: genome \u2018hot regions,\u2019 genes, new potential candidates and future directions","volume":"13","author":"Serretti","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib277","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/sj.npp.1300555","article-title":"Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography","volume":"29","author":"Sheline","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib278","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00004583-199706000-00010","article-title":"Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity","volume":"36","author":"Sherman","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib279","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0006-3223(03)00544-4","article-title":"Serotonin transporters in obsessive\u2013compulsive disorder: a positron emission tomography study with [(11)C]McN 5652","volume":"54","author":"Simpson","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib280","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/appi.ajp.159.8.1329","article-title":"Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET","volume":"159","author":"Singer","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib281","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-003-1700-y","article-title":"123I-Beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia","volume":"173","author":"Sjoholm","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib282","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.biopsych.2006.12.008","article-title":"Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane","volume":"62","author":"Spencer","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib283","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biopsych.2005.06.012","article-title":"Sex differences in diencephalon serotonin transporter availability in major depression","volume":"59","author":"Staley","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib284","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0924-977X(00)00134-6","article-title":"No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECT-study","volume":"11","author":"Stamenkovic","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Suppl 14","key":"10.1016\/j.bbr.2009.06.009_bib285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S1092852900026900","article-title":"Psychobiology of anxiety disorders and obsessive\u2013compulsive spectrum disorders","volume":"13","author":"Stein","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1016\/j.bbr.2009.06.009_bib286","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3810\/pgm.2008.09.1908","article-title":"Special issues in the diagnosis and treatment of ADHD in adolescents","volume":"120","author":"Steinhoff","year":"2008","journal-title":"Postgrad Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib287","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00406-004-0489-y","article-title":"Reduced serotonin transporter-availability in obsessive\u2013compulsive disorder (OCD)","volume":"254","author":"Stengler-Wenzke","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib288","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000090702","article-title":"Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive\u2013compulsive disorder","volume":"53","author":"Stengler-Wenzke","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbr.2009.06.009_bib289","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF02253582","article-title":"D1 dopamine receptor binding in mood disorders measured by positron emission tomography","volume":"106","author":"Suhara","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.06.009_bib290","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S1461145703003699","article-title":"Decreased thalamic D2\/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457","volume":"6","author":"Talvik","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2009.06.009_bib291","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pscychresns.2006.05.009","article-title":"Dopamine D2 receptor binding in drug-na\u00efve patients with schizophrenia examined with raclopride-C11 and positron emission tomography","volume":"148","author":"Talvik","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib292","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archpsyc.59.6.514","article-title":"Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635","volume":"59","author":"Tauscher","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib293","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0893-133X(00)00165-2","article-title":"In vivo measurement of the vesicular monoamine transporter in schizophrenia","volume":"23","author":"Taylor","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib294","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0193-953X(01)00003-X","article-title":"Developmental neurobiology of childhood stress and trauma","volume":"25","author":"Teicher","year":"2002","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.bbr.2009.06.009_bib295","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1528-1167.2007.01089.x","article-title":"Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy","volume":"48","author":"Theodore","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbr.2009.06.009_bib296","first-page":"39","article-title":"A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls","volume":"22","author":"Tibbo","year":"1997","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.bbr.2009.06.009_bib297","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/ajp.154.2.239","article-title":"Dopamine reuptake site densities in patients with social phobia","volume":"154","author":"Tiihonen","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib298","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.mp.4000329","article-title":"Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis","volume":"2","author":"Tiihonen","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib299","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11920-007-0041-7","article-title":"Dopamine hypothesis of schizophrenia: making sense of it all","volume":"9","author":"Toda","year":"2007","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.bbr.2009.06.009_bib300","first-page":"163","article-title":"Alterations of benzodiazepine receptor binding potential in anxiety and somatoform disorders measured by 123I-iomazenil SPECT","volume":"15","author":"Tokunaga","year":"1997","journal-title":"Radiat Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib301","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-244X-4-27","article-title":"Elevated midbrain serotonin transporter availability in mixed mania: a case report","volume":"4","author":"Tolmunen","year":"2004","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib302","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0920-9964(98)00014-0","article-title":"No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET","volume":"31","author":"Trichard","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib303","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-1781(93)90063-M","article-title":"Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone","volume":"49","author":"Tune","year":"1993","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib304","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0925-4927(96)02728-X","article-title":"Striatal dopamine D2 receptor quantification and superior temporal gyrus: volume determination in 14 chronic schizophrenic subjects","volume":"67","author":"Tune","year":"1996","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib305","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jnnp.57.6.688","article-title":"PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome","volume":"57","author":"Turjanski","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib306","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/10598405050210030401","article-title":"School phobia","volume":"21","author":"Tyrrell","year":"2005","journal-title":"J Sch Nurs"},{"key":"10.1016\/j.bbr.2009.06.009_bib307","first-page":"41","article-title":"Assessment of cerebral benzodiazepine receptor distribution in anxiety disorders by 123I-iomazenil-SPECT: comparison to cerebral perfusion scintigraphy by 123I-IMP","volume":"57","author":"Uchiyama","year":"1997","journal-title":"Nippon Igaku Hoshasen Gakkai Zasshi"},{"key":"10.1016\/j.bbr.2009.06.009_bib308","first-page":"203","article-title":"Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients","volume":"38","author":"Vallabhajosula","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib309","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1176\/appi.ajp.2008.08071109","article-title":"Longitudinal PET imaging in a patient with schizophrenia did not show marked changes in dopaminergic function with relapse of psychosis","volume":"165","author":"Valli","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib310","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"Van Berckel","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib311","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1176\/appi.ajp.161.12.2201","article-title":"Enhanced dopamine transporter density in psychotropic-naive patients with obsessive\u2013compulsive disorder shown by [123I]{beta}-CIT SPECT","volume":"161","author":"Van der Wee","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib312","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2967\/jnumed.107.045518","article-title":"Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT","volume":"49","author":"Van der Wee","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib313","first-page":"638","article-title":"The genetics of the Gilles de la Tourette syndrome: a review","volume":"121","author":"Van de Wetering","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib314","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1176\/appi.ajp.159.2.309","article-title":"Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder","volume":"159","author":"Van Dyck","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib315","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0327(01)00482-7","article-title":"Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide","volume":"74","author":"Van Heeringen","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib316","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0925-4927(99)00027-X","article-title":"[123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia","volume":"91","author":"Verhoeff","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib317","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-1781(00)00198-0","article-title":"A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia","volume":"99","author":"Verhoeff","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib318","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.neuroimage.2006.10.014","article-title":"Brain dopamine transporter levels in treatment and drug naive adults with ADHD","volume":"34","author":"Volkow","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbr.2009.06.009_bib319","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.64.8.932","article-title":"Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit\/hyperactivity disorder","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib320","article-title":"Tourette syndrome","volume":"99","author":"Walkup","year":"2006","journal-title":"Adv Neurol"},{"key":"10.1016\/j.bbr.2009.06.009_bib321","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0006-3223(99)00293-0","article-title":"[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder","volume":"47","author":"Willeit","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib322","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-0173(83)90005-X","article-title":"Dopamine and depression: a review of recent evidence. I. Empirical studies","volume":"287","author":"Willner","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib323","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.273.5279.1225","article-title":"Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding","volume":"273","author":"Wolf","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbr.2009.06.009_bib324","first-page":"595","article-title":"Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report","volume":"21","author":"Wong","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.bbr.2009.06.009_bib325","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.2878495","article-title":"Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics","volume":"234","author":"Wong","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.bbr.2009.06.009_bib326","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00004647-199703000-00010","article-title":"Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness","volume":"17","author":"Wong","year":"1997","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.bbr.2009.06.009_bib327","first-page":"1243","article-title":"D2-like dopamine receptor density in Tourette syndrome measured by PET","volume":"38","author":"Wong","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bbr.2009.06.009_bib328","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","article-title":"Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET","volume":"33","author":"Wong","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib329","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0925-4927(03)00066-0","article-title":"Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls","volume":"123","author":"Yang","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib330","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1176\/appi.ajp.161.8.1496","article-title":"Associated alterations of striatal dopamine D2\/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study","volume":"161","author":"Yang","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib331","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pscychresns.2007.08.008","article-title":"Greater availability of dopamine transporters in patients with major depression\u2014a dual-isotope SPECT study","volume":"162","author":"Yang","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib332","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1176\/appi.ajp.161.6.1016","article-title":"Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia","volume":"161","author":"Yasuno","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib333","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.biopsych.2003.11.016","article-title":"Decreased 5-HT1A receptor binding in amygdala of schizophrenia","volume":"55","author":"Yasuno","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib334","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/archpsyc.57.9.850","article-title":"Brain serotonin2 receptors in major depression: a positron emission tomography study","volume":"57","author":"Yatham","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib335","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1176\/appi.ajp.159.5.768","article-title":"PET study of [(18)F]6-fluoro-l-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium","volume":"159","author":"Yatham","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.06.009_bib336","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.mnm.0000239485.53780.16","article-title":"Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults","volume":"27","author":"Yeh","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.bbr.2009.06.009_bib337","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pscychresns.2007.01.003","article-title":"Phasic dysfunction of dopamine transmission in Tourette's syndrome evaluated with 99mTc TRODAT-1 imaging","volume":"156","author":"Yeh","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib338","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.schres.2004.03.015","article-title":"Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia","volume":"71","author":"Yoder","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.06.009_bib339","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1521\/pedi.2007.21.5.518","article-title":"The essential nature of borderline psychopathology","volume":"21","author":"Zanarini","year":"2007","journal-title":"J Pers Disord"},{"key":"10.1016\/j.bbr.2009.06.009_bib340","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/sj.npp.1301290","article-title":"[123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive\u2013compulsive checkers","volume":"32","author":"Zitterl","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.06.009_bib341","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00115-006-2202-z","article-title":"Anxiety disorders. Causes, clinical picture and treatment","volume":"78","author":"Zwanzger","year":"2007","journal-title":"Nervenarzt"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432809003556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432809003556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:57:50Z","timestamp":1759064270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432809003556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":341,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0166432809003556"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2009.06.009","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2009.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}